Saline vs. clot-busting drug for brain bleeding drainage
Treatments studied
Part of Brain & nervous system clinical trials.
This study compares two methods to clear blood from the fluid chambers in your brain after a bleed. Researchers want to see if a clot-dissolving medication (TPA) works better than standard salt solution when delivered through a drainage tube.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have bleeding inside the brain (intraventricular hemorrhage) requiring a drainage tube placed by neurosurgery
- Your baseline disability level is minimal (able to care for yourself or have minor symptoms only)
- Treatment can start within 24 hours of your hospital arrival
- Your bleeding was NOT caused by head injury or trauma
- You do not show severe brainstem damage (like loss of reflexes or fixed, dilated pupils)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of intravenous fluids (saline vs. balanced crystalloids) given to people with traumatic brain injury when they arrive in the emergency room. The goal is to find out which fluid leads to better outcomes.
This trial tests a clot-busting drug (rhTNK-tPA) to remove blood from the ventricles (fluid spaces deep in the brain) after a spontaneous brain bleed. It may help patients whose ventricles are blocked by a large clot, reducing pressure and improving recovery.
This study tests whether giving extra normal (saltwater) fluid after standard clot-busting treatment improves recovery after a stroke. It could help reduce damage and improve outcomes for people who have had a moderate to severe stroke.
This trial tests whether giving a drug called tranexamic acid (helps stop bleeding) along with very careful blood pressure lowering can reduce bleeding growth and improve recovery after a brain bleed. It is for people who arrive at the hospital very quickly (within 2 hours) after symptoms start.
This trial tests a rapid procedure to remove a blood clot in the brain after a specific type of stroke. It might help people with a moderate-sized bleed in the front part of the brain if treatment can start within 24 hours.
This study tests a new way to remove brain blood clots using a small tube and a clot-busting medicine (tenecteplase). It aims to help people recover better after a specific type of bleeding in the brain.
Hear when a new Tissue Plasminogen Activator trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.